Clinical Trial Update: Exemestane in Treating Postmenopausal Women With Resected Stage I, Stage II, or Stage IIIA Breast Cancer Who Have Completed 5 Years of Tamoxifen [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating exemestane as adjuvant therapy after five years of tamoxifen in postmenopausal women with resected Stage I-IIIA breast cancer; t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Aromasin (exemestane)

Snippet

Sponsor: NSABP Foundation Inc | Conditions: Breast Cancer | Phase 3 | Status: COMPLETED